Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Infinity Pharmaceuticals (INFI)

Infinity Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INFI
DateTimeSourceHeadlineSymbolCompany
13/09/202313:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
12/09/202323:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INFIInfinity Pharmaceuticals Inc
11/09/202321:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
01/09/202321:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
10/08/202321:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INFIInfinity Pharmaceuticals Inc
25/07/202321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
25/07/202321:05Business WireInfinity Pharmaceuticals Announces Value Preservation and Maximization PlanNASDAQ:INFIInfinity Pharmaceuticals Inc
24/07/202313:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
24/07/202313:30Business WireInfinity Pharmaceuticals Announces Termination of Merger Agreement with MEI PharmaNASDAQ:INFIInfinity Pharmaceuticals Inc
14/07/202321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
14/07/202318:00Business WireInfinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI PharmaNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202313:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202313:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
10/07/202313:30Business WireInfinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)NASDAQ:INFIInfinity Pharmaceuticals Inc
05/07/202313:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
05/07/202313:30Business WireISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.NASDAQ:INFIInfinity Pharmaceuticals Inc
03/07/202321:57Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:INFIInfinity Pharmaceuticals Inc
03/07/202321:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
03/07/202313:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
30/06/202321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
29/06/202311:01Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
27/06/202313:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
21/06/202313:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
20/06/202313:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
20/06/202313:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INFIInfinity Pharmaceuticals Inc
16/06/202317:34Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
16/06/202313:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
15/06/202317:08Business WireMEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology CandidatesNASDAQ:INFIInfinity Pharmaceuticals Inc
15/06/202313:00Business WireMEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology CandidatesNASDAQ:INFIInfinity Pharmaceuticals Inc
06/06/202321:44Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:INFI